ScripsAmerica to Meet with Pharmaceutical Distributors Throughout China to Generate RapiMed(R) Purchase Orders
October 28 2013 - 8:30AM
ScripsAmerica, Inc. (OTCBB:SCRC) announced today
that the Company's due diligence team will travel to China in
November to begin formal RapiMed® distribution negotiations in
preparation for a product launch into the Chinese OTC market,
valued at over $32 billion. ScripsAmerica plans to secure
distribution commitments for its RapiMed® children's pain reliever
and fever reducer during its upcoming five city trip across China.
Representatives of the Company will conduct several meetings with
hospitals, pharmacies, multi-level marketing companies and
pharmaceutical sales networks. "We are very excited to visit our
partners in China who've already generated significant interest in
RapiMed®. Because it's a truly unique product that addresses
China's current problem with dangerous counterfeit medications
flooding the market, we expect to generate several attractive
distribution opportunities during our upcoming trip. ScripsAmerica
believes RapiMed®'s ease of delivery and American-made quality
assurance is the right product at the right time for the Chinese
market. We are confident that our upcoming ventures in China will
produce strong sales revenue for ScripsAmerica, greatly benefitting
our shareholders," said CEO, Bob Schneiderman.
Schneiderman continued, "Our team will conduct pharmaceutical
distribution meetings in the cities of Hong Kong, Chengdu, Yantai,
Shenzhen and Beijing. Additionally, the Company has already begun
to formally register RapiMed® with the Chinese State Food and Drug
Administration which will allow ScripsAmerica to market and sell
RapiMed® throughout the Chinese Market."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and
nutraceutical drugs, delivering pharmaceutical products to a wide
range of end users across the health care industry. End users
include retail pharmacies, hospitals, long-term care facilities and
government and home care agencies. For more information visit
www.ScripsAmerica.com. Safe Harbor Statement
This release includes forward-looking statements, which are
based on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in the
economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
CONTACT: 888-959-7095
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Apr 2024 to May 2024
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From May 2023 to May 2024